Similar articles

• Amentoflavone suppresses tumor growth in ovarian cancer by modulating Skp2.

  Liu H, Yue Q, He S. Liu H, et al. Life Sci. 2017 Nov 15;189:96-105. doi: 10.1016/j.lfs.2017.09.026. Epub 2017 Sep 20. Life Sci. 2017. Retraction in: Life Sci. 2024 May 1;344:122585. doi: 10.1016/j.lfs.2024.122585. PMID: 28942285 Retracted.
• Retraction notice to "Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma" [Life Sci. 247 (2020) 117425].

  Chen Y, Li N, Wang H, Wang N, Peng H, Wang J, Li Y, Liu M, Li H, Zhang Y, Wang Z. Chen Y, et al. Life Sci. 2024 May 1;344:122588. doi: 10.1016/j.lfs.2024.122588. Epub 2024 Mar 23. Life Sci. 2024. PMID: 38521619 No abstract available.
• Retraction notice to "Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway" [Life Sci. 209 (2018) 498-506].

  Wang N, Zhou F, Guo J, Zhu H, Luo S, Cao J. Wang N, et al. Life Sci. 2024 May 1;344:122586. doi: 10.1016/j.lfs.2024.122586. Epub 2024 Mar 23. Life Sci. 2024. PMID: 38521620 No abstract available.
• Retraction notice to "Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling" [Biomed Pharmacother. 107 (2018) 243-253].

  Liu B, Yu S. Liu B, et al. Biomed Pharmacother. 2020 Oct;130:110635. doi: 10.1016/j.biopha.2020.110635. Epub 2020 Aug 23. Biomed Pharmacother. 2020. PMID: 32843235 No abstract available.
• Retraction notice to "Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2" [Biomed. Pharmacother. 95 (2017) 1129-1138].

  Li W, Li F, Zhu Y, Song D. Li W, et al. Biomed Pharmacother. 2021 Dec;144:112386. doi: 10.1016/j.biopha.2021.112386. Epub 2021 Nov 10. Biomed Pharmacother. 2021. PMID: 34772577 No abstract available.